PopVax

PopVax is an Indian full-stack biotechnology startup harnessing the power of mRNA and computational protein design to fulfill our mission of developing, manufacturing, and deploying billions of vaccine doses over the next decade to save 1 million lives per year across the world. Since founding in late 2021, we have developed a novel mRNA architecture, lipid nanoparticle (LNP) delivery platform for mRNA, and a generative AI-enabled computational approach to vaccine design to combat diseases against which existing vaccine design approaches have failed. We use our end-to-end capabilities in mRNA biomedicine development to rapidly advance new vaccines from concept to clinic — every month we delay represents hundreds of thousands of lives lost.